Trexquant Investment LP purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 4,439 shares of the company’s stock, valued at approximately $297,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. FTB Advisors Inc. boosted its position in Cardinal Health by 31.0% during the third quarter. FTB Advisors Inc. now owns 4,836 shares of the company’s stock worth $324,000 after purchasing an additional 1,143 shares during the period. ETRADE Capital Management LLC boosted its position in Cardinal Health by 12.7% during the third quarter. ETRADE Capital Management LLC now owns 34,983 shares of the company’s stock worth $2,341,000 after purchasing an additional 3,940 shares during the period. Covenant Multifamily Offices LLC boosted its position in Cardinal Health by 3.8% during the third quarter. Covenant Multifamily Offices LLC now owns 64,222 shares of the company’s stock worth $4,298,000 after purchasing an additional 2,370 shares during the period. Van ECK Associates Corp boosted its position in Cardinal Health by 883.9% during the third quarter. Van ECK Associates Corp now owns 260,666 shares of the company’s stock worth $17,444,000 after purchasing an additional 234,172 shares during the period. Finally, MUFG Securities EMEA plc bought a new stake in Cardinal Health during the third quarter worth approximately $7,361,000. 88.47% of the stock is owned by institutional investors and hedge funds.

Cardinal Health, Inc. (CAH) opened at $60.35 on Wednesday. Cardinal Health, Inc. has a 1-year low of $54.66 and a 1-year high of $84.88. The company has a market capitalization of $19,197.11, a P/E ratio of 11.58, a PEG ratio of 1.76 and a beta of 0.85. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.24 earnings per share. equities research analysts anticipate that Cardinal Health, Inc. will post 4.97 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be paid a $0.4624 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.06%. Cardinal Health’s payout ratio is 53.78%.

A number of brokerages have issued reports on CAH. UBS reaffirmed a “neutral” rating and set a $76.00 target price (down previously from $79.00) on shares of Cardinal Health in a research report on Wednesday, August 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardinal Health in a research report on Sunday, September 10th. Robert W. Baird reiterated a “hold” rating and set a $73.00 price target on shares of Cardinal Health in a report on Sunday, September 17th. Royal Bank Of Canada started coverage on Cardinal Health in a report on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 price target for the company. Finally, Mizuho set a $70.00 price target on Cardinal Health and gave the stock a “hold” rating in a report on Tuesday, October 24th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $73.91.

WARNING: “Trexquant Investment LP Purchases Shares of 4,439 Cardinal Health, Inc. (CAH)” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2017/12/06/trexquant-investment-lp-purchases-shares-of-4439-cardinal-health-inc-cah.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.